YU66202A - Sistem za kontrolisano otpuštanje ciprofloksacina nakon oralne primene u jednoj dnevnoj dozi - Google Patents
Sistem za kontrolisano otpuštanje ciprofloksacina nakon oralne primene u jednoj dnevnoj doziInfo
- Publication number
- YU66202A YU66202A YU66202A YUP66202A YU66202A YU 66202 A YU66202 A YU 66202A YU 66202 A YU66202 A YU 66202A YU P66202 A YUP66202 A YU P66202A YU 66202 A YU66202 A YU 66202A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- ciprofloxacin
- once daily
- delivery system
- orally administered
- daily administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Formulacija za kontrolisano otpuštanje ciprofloksacina nakon oralne primene u jednoj dnevnoj dozi u vidu tablete za humanu upotrebu sadrži farmaceutski prihvatljivu količinu ciprofloksacina, od oko 0,1% (w/w) do oko 8,0% (w/w) komponente velike viskoznosti i/ili sredstva za gelatinizaciju, od oko 5,0% (w/w) do oko 15% (w/w) sredstva za stvaranje gas, i oko 30% (w/w) do oko 15% (w/w) sredstva za bubrenje.[A once daily tablet formulation for oral administration in humans for the controlled release of ciprofloxacin comprising a pharmaceutically effective amount of ciprofloxacin, from about 0.1 % to about 8.0 % of a viscolyzing agent and/or a gelling agent, about 5.0% to about 15 % of a gas generating agent, and about 3.0 % to about 15 % of a swelling agent, said percentages being w/w of the composition.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51788700A | 2000-03-03 | 2000-03-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU66202A true YU66202A (sh) | 2005-09-19 |
Family
ID=24061635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU66202A YU66202A (sh) | 2000-03-03 | 2001-02-28 | Sistem za kontrolisano otpuštanje ciprofloksacina nakon oralne primene u jednoj dnevnoj dozi |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP1263409A1 (sh) |
| JP (1) | JP2003525229A (sh) |
| KR (1) | KR20030009374A (sh) |
| CN (1) | CN1420763A (sh) |
| AP (2) | AP2001002084A0 (sh) |
| AR (1) | AR032614A1 (sh) |
| AU (1) | AU3589701A (sh) |
| BG (1) | BG107055A (sh) |
| BR (1) | BR0108958A (sh) |
| CA (1) | CA2400950A1 (sh) |
| CZ (1) | CZ20022883A3 (sh) |
| DO (1) | DOP2001000130A (sh) |
| EA (1) | EA200200914A1 (sh) |
| EC (1) | ECSP013952A (sh) |
| EE (1) | EE200200497A (sh) |
| GT (1) | GT200100033A (sh) |
| HN (1) | HN2001000038A (sh) |
| HR (1) | HRP20020715A2 (sh) |
| HU (1) | HUP0204417A3 (sh) |
| IL (1) | IL151553A0 (sh) |
| IS (1) | IS6532A (sh) |
| MX (1) | MXPA02008568A (sh) |
| NO (1) | NO20024108L (sh) |
| NZ (1) | NZ520927A (sh) |
| OA (1) | OA12381A (sh) |
| PE (1) | PE20011113A1 (sh) |
| PL (1) | PL365071A1 (sh) |
| SK (1) | SK12542002A3 (sh) |
| WO (1) | WO2001064183A1 (sh) |
| YU (1) | YU66202A (sh) |
| ZA (1) | ZA200206764B (sh) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0209265D0 (en) | 2002-04-23 | 2002-06-05 | Novartis Ag | Organic compounds |
| US20030229101A1 (en) * | 2002-06-06 | 2003-12-11 | Sherman Bernard Charles | Tablets comprising ciprofloxacin hydrochloride |
| DE10351448A1 (de) | 2003-11-04 | 2005-06-09 | Bayer Healthcare Ag | Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften |
| EP1745775B1 (en) * | 2005-07-19 | 2008-05-28 | Ethypharm | Gastroretentive formulations and manufacturing process thereof. |
| EP1880722B1 (en) * | 2006-07-19 | 2010-03-17 | Tabuk Pharmaceutical Manufacturing Co. | Pharmaceutical compositions of ciprofloxacin |
| WO2016115253A1 (en) | 2015-01-14 | 2016-07-21 | The Regents Of The University Ofcolordo, A Body Corporate | Insulin mimotopes and methods of using the same |
| EP3419669A4 (en) * | 2016-02-23 | 2019-10-30 | Matripharm International Inc. | DOUBLE-SPEED RELEASE COMPOSITION WITH HIGH MEDICAL DRUG CHARGE |
| AU2017236977B2 (en) | 2016-03-24 | 2022-05-26 | Immunomolecular Therapeutics, Inc. | Methods of treating autoimmune disease |
| US11052060B2 (en) | 2018-02-12 | 2021-07-06 | The Regents Of The University Of Colorado, A Body Corporate | Compounds and methods for treating autoimmunity |
| US11013707B2 (en) | 2018-03-23 | 2021-05-25 | The Regents Of The University Of Colorado, A Body Corporate | Administration of oral methyldopa |
| CN109806237A (zh) * | 2019-03-13 | 2019-05-28 | 悦康药业集团上海制药有限公司 | 一种乳酸环丙沙星泡腾片及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5096714A (en) * | 1988-06-28 | 1992-03-17 | Hauser-Kuhrts, Inc. | Prolonged release drug tablet formulations |
| JPH0624959A (ja) * | 1991-10-04 | 1994-02-01 | Bayer Yakuhin Kk | 胃内浮遊型薬物徐放性固形製剤 |
| DE4406424A1 (de) * | 1994-02-28 | 1995-08-31 | Bayer Ag | Expandierbare Arzneiformen |
| DE19839057A1 (de) * | 1998-08-28 | 2000-03-02 | Koch Berthold | Spülluft-Regler für eine Trockenvorrichtung für Druckluft |
| EA004443B1 (ru) * | 1998-09-14 | 2004-04-29 | Рэнбакси Лабораториз Лимитед | Лекарственная форма для контролируемого высвобождения ципрофлоксацина для приема один раз в день |
-
2001
- 2001-02-28 WO PCT/IB2001/000279 patent/WO2001064183A1/en not_active Application Discontinuation
- 2001-02-28 AP APAP/P/2001/002084A patent/AP2001002084A0/en unknown
- 2001-02-28 CZ CZ20022883A patent/CZ20022883A3/cs unknown
- 2001-02-28 AR ARP010100957A patent/AR032614A1/es not_active Application Discontinuation
- 2001-02-28 AU AU35897/01A patent/AU3589701A/en not_active Abandoned
- 2001-02-28 HU HU0204417A patent/HUP0204417A3/hu unknown
- 2001-02-28 CA CA002400950A patent/CA2400950A1/en not_active Abandoned
- 2001-02-28 CN CN01805998A patent/CN1420763A/zh active Pending
- 2001-02-28 SK SK1254-2002A patent/SK12542002A3/sk unknown
- 2001-02-28 PL PL01365071A patent/PL365071A1/xx not_active Application Discontinuation
- 2001-02-28 OA OA1200200267A patent/OA12381A/en unknown
- 2001-02-28 AP APAP/P/2002/002627A patent/AP1485A/en active
- 2001-02-28 EP EP01908038A patent/EP1263409A1/en not_active Withdrawn
- 2001-02-28 YU YU66202A patent/YU66202A/sh unknown
- 2001-02-28 JP JP2001563081A patent/JP2003525229A/ja not_active Withdrawn
- 2001-02-28 EE EEP200200497A patent/EE200200497A/xx unknown
- 2001-02-28 KR KR1020027011441A patent/KR20030009374A/ko not_active Application Discontinuation
- 2001-02-28 MX MXPA02008568A patent/MXPA02008568A/es unknown
- 2001-02-28 IL IL15155301A patent/IL151553A0/xx unknown
- 2001-02-28 BR BR0108958-7A patent/BR0108958A/pt not_active Withdrawn
- 2001-02-28 NZ NZ520927A patent/NZ520927A/xx unknown
- 2001-02-28 EA EA200200914A patent/EA200200914A1/ru unknown
- 2001-03-01 EC EC2001003952A patent/ECSP013952A/es unknown
- 2001-03-01 GT GT200100033A patent/GT200100033A/es unknown
- 2001-03-01 PE PE2001000206A patent/PE20011113A1/es not_active Application Discontinuation
- 2001-03-02 HN HN2001000038A patent/HN2001000038A/es unknown
- 2001-03-02 DO DO2001000130A patent/DOP2001000130A/es unknown
-
2002
- 2002-08-23 ZA ZA200206764A patent/ZA200206764B/en unknown
- 2002-08-28 IS IS6532A patent/IS6532A/is unknown
- 2002-08-28 NO NO20024108A patent/NO20024108L/no unknown
- 2002-08-30 HR HRP20020715 patent/HRP20020715A2/hr not_active Application Discontinuation
- 2002-09-02 BG BG107055A patent/BG107055A/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX339071B (es) | Almidon pregelatinizado en una formulacion de liberacion controlada. | |
| MY118371A (en) | Tetrahydrolipstatin containing compositions | |
| PL334656A1 (en) | Dosage forms and methods of achieving betterement in cases of erection disorderamong male patients | |
| IL143375A0 (en) | Sustained release matrix systems for highly soluble drugs | |
| BG105339A (en) | Orally administered controlled drug delivery system providing temporal and spatial control | |
| AU2001263228A1 (en) | Rapidly disintegrating solid oral dosage form | |
| GEP20022851B (en) | Flash-Melt Oral Dosage Formulation | |
| IS1694B (is) | Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara | |
| MXPA04003807A (es) | Formulaciones farmaceuticas de 5, 7, 14-trianzatetraciclo [10.3.1.02, 11, 04, 9]-hexadeca -2 (11), 3, 5, 7, 9-pentaeno. | |
| AU3846901A (en) | Oral, nasal and pulmonary dosage formualtions of copolymer 1 | |
| NO306894B1 (no) | Anvendelse av galanthamin for fremstilling av en farmasöytisk formulering for behandling av nikotinavhengighet | |
| HK1087336A1 (en) | Pharmaceutical composition comprising lumiracoxib | |
| AP1485A (en) | Orally administered controlled delivery system for once daily administration of ciprofloxacin. | |
| ES2130081B1 (es) | Comprimido de maleato de trimebutina con recubrimiento laminar. | |
| WO2002011694A3 (en) | COMPOSITIONS AND DOSAGE FORMS FOR APPLICATION IN ORAL CAVITY IN THE TREATMENT OF MYCOSIS | |
| BR0013719A (pt) | Dosagem oral de liberaçâo controlada, apropriada para administração oral | |
| MY129314A (en) | Pharmaceutical composition comprising sumatriptan | |
| MXPA06000332A (es) | Nueva composicion farmaceutica solida que comprende amisulprida. | |
| HRP20020258B1 (en) | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive | |
| GEP20043377B (en) | Pharmaceutical Complex | |
| AU2503900A (en) | Sulfated phosphatidylinositols, their preparation and use | |
| UY26605A1 (es) | Sistema de administración oral controlada para la ingestión diaria de ciprofloxacina | |
| ECSP982396A (es) | Composiciones que contienen tetrahidrolipstatina | |
| AU2001295839A1 (en) | Use of agents active against candida in the treatment of disorders of the oral and intestinal mucosa | |
| MY145885A (en) | Controlled release formulations for oral administration |